Chart calendar Perspective Therapeutics, Inc.

dfd5e9d5057a62528cf1c3f2.l3A2om8G0But3tJFMaDaNGs-UVyRQWWP7BdgR1M5SoE.8T8A1zZA6VDit4IuYO6FAx9mPAjOBw2_inIPfiluEuPfBEbJDj_odsCvpQ~0173067d71c8fa0fdaf56adefd67c254

Upcoming events on Perspective Therapeutics, Inc.

No events available

Past events on Perspective Therapeutics, Inc.

2026-08-10

Earnings release - Q2 2026

2026-05-27

Annual General Meeting

10:00 am
2026-05-11

Earnings release - Q1 2026

2026-05-04

Présentation aux Actionnaires / Analystes

08:30 am
2026-03-16

Earnings release - Annual 2025

2025-11-10

Earnings release - Q3 2025

2025-10-20

Information meeting

08:30 am

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
1,43
8,46
-83.04%
1,45
1,46
-0.34%
0,88
1,07
-17.46%

0,34


0,40


13,4

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
-64,5
-62,5
-3.18%
-110
-102
-8.35%

-125


-139


-145

EBIT
Million USD
Released
Forecast
Spread
-40,9
-43,4
5.6%
-66,8
-67,1
0.48%
-114
-103
-9.76%

-123


-144


-145

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-40,1
-43,0
6.64%
-80,4
-58,1
-38.42%
-104
-95,1
-9.84%

-115


-138


-134

Net income
Million USD
Released
Forecast
Spread
-46,5
-37,7
-23.33%
-79,3
-58,0
-36.62%
-103
-94,1
-9.57%

-115


-137


-139

EPS
USD
Released
Forecast
Spread
-1,70
-1,40
-21.43%
-1,23
-0,66
-87.27%
-1,40
-1,25
-11.82%

-1,03


-1,11


-1,04

Announcement Date28/03/2426/03/2516/03/26-

Quarterly results

Fiscal PeriodJune 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
0,23
0,28
-15.61%
0,34
0,14
137.62%
0,29
0,17
70.22%
0,21
0,21
1.04%
0,04
0,24
-81.86%
0,08
0,14
-44.6%
0,08
0,09
-12.39%

0,04


0,05


0,05


0,01


0,01


0,01

EBITDA
Million USD
Released
Forecast
Spread
-20,2
-17,6
-14.42%
-21,1
-19,5
-7.96%
-23,3
-19,8
-17.54%
-27,1
-21,7
-24.85%
-38,8
-25,5
-52.26%
-27,2
-39,7
31.6%
-28,1
-29,2
3.72%

-34,0


-43,7













EBIT
Million USD
Released
Forecast
Spread
-20,9
-21,2
1.47%
-21,8
-23,0
5.05%
-24,0
-24,0
-0.28%
-27,9
-26,0
-7.32%
-39,8
-29,7
-33.98%
-28,3
-33,9
16.5%
-29,3
-30,5
4.08%

-31,5


-33,6


-33,0


-34,1


-35,2


-36,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-41,3
-18,6
-122.37%
-18,2
-22,4
18.96%
-22,0
-22,5
2.33%
-26,0
-24,6
-5.7%
-38,3
-29,0
-31.92%
-26,2
-32,0
18.19%
-27,0
-29,1
7.27%

-29,9


-31,5


-31,5


-32,7


-34,2


-35,5

Net income
Million USD
Released
Forecast
Spread
-40,2
-18,5
-116.65%
-18,2
-22,4
18.96%
-21,5
-22,1
2.64%
-26,0
-24,4
-6.41%
-37,5
-28,3
-32.38%
-26,2
-32,2
18.77%
-26,8
-29,0
7.78%

-29,9


-32,1


-31,3


-32,7


-34,2


-35,6

EPS
USD
Released
Forecast
Spread
-0,61
-0,24
-152.55%
-0,25
-0,31
18.34%
-0,29
-0,30
2.08%
-0,35
-0,32
-7.88%
-0,51
-0,36
-40.94%
-0,25
-0,30
17.03%
-0,22
-0,26
14.27%

-0,25


-0,27


-0,29


-0,30


-0,29


-0,29

Announcement Date26/03/2512/05/2513/08/2510/11/2516/03/2611/05/2610/08/26------
2026-08-19

Board of Directors Meeting

2026-08-19

Earnings release - Q2 2026

P
2026-08-19

Earnings release - Q2 2026

2026-08-19

Earnings release - Q2 2026

2026-08-19

Information meeting

2026-08-20

Earnings release - Q2 2026

2026-08-20

Earnings presentation

07:00 pm
2026-08-20

Earnings release - Q2 2026

2026-08-20

Earnings presentation

08:00 am
2026-08-24

Ex-dividend date - 0.08 USD

12:00 am

Past sector events for Perspective Therapeutics, Inc.

Today

Earnings release - Q2 2026

Today

Earnings presentation

10:00 am
2026-08-16

Earnings presentation

07:15 pm
2026-08-15

Earnings release - Q2 2026

2026-08-14

Board of Directors Meeting

2026-08-14

Earnings presentation

08:30 am
2026-08-14

Earnings release - Q1 2027

2026-08-13

Earnings presentation

08:00 am
2026-08-13

Earnings release - Q2 2026

2026-08-13

Board of Directors Meeting

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CATX Stock
  4. Calendar Perspective Therapeutics, Inc.